In the dynamic and competitive landscape of the pharmaceutical industry, companies seek strategic partnerships that offer comprehensive solutions to streamline their processes. With a global footprint spanning five locations around the world, we are emerging as a leading force in the Contract Development and Manufacturing Organization (CDMO) sector.
A global integrated CDMO
Henny Zijlstra, our Chief Commercial Officer, sheds light on the significance of the company’s global network for clients. She emphasizes how the trend in the industry involves the consolidation of CDMO networks. Adragos Pharma, by offering an integrated network across five locations, becomes a one-stop solution for clients. Henny notes, “We can do the development and the manufacturing part, including our Japanese angle. So you can really cover almost the whole world, and that is an advantage.”
One stop shop
One of the most apparent advantages is the reduction of redundancy and complexity. Henny explains that clients no longer need to navigate the intricacies of multiple certifications and quality agreements. We provide a seamless experience by incorporating all necessary aspects into one comprehensive package. This not only saves time but also ensures consistency and compliance across the board.
Save time with one partner
Gael Le Saux, Site Head at Livron, dives into the time-consuming nature of CMO (Contract Manufacturing Organization) management. He highlights how managing multiple partners for various products can be resource-intensive for pharmaceutical companies. In contrast, having a global network like Adragos offers a significant resource advantage for clients.
Gael elaborates, “CMO management is really time-consuming. So having a global network is a lot of resources for our customers. If they can have a single partner for many different types of products, then it’s really an added value for them.” The ability to work with a single partner across diverse product lines reduces the complexity of coordination and communication. Clients can focus on their core competencies while Adragos takes care of the intricacies of the manufacturing process, offering a streamlined and efficient partnership.
Adragos’ global footprint emerges as a strategic asset for pharmaceutical clients seeking a reliable and comprehensive CDMO partner. The integrated network across five locations not only facilitates worldwide coverage but also simplifies and accelerates the development and manufacturing processes. The reduction in administrative burdens, combined with the efficient use of resources, positions Adragos Pharma as a valuable partner in navigating the complexities of the pharmaceutical industry. As the industry continues to evolve, we stand as an innovative and efficient company that provides clients with the competitive edge they need in the global market.
